Corvus Pharmaceuticals Inc banner

Corvus Pharmaceuticals Inc
NASDAQ:CRVS

Watchlist Manager
Corvus Pharmaceuticals Inc Logo
Corvus Pharmaceuticals Inc
NASDAQ:CRVS
Watchlist
Price: 19.58 USD -4.07% Market Closed
Market Cap: $1.5B

Wall Street
Price Targets

CRVS Price Targets Summary
Corvus Pharmaceuticals Inc

Wall Street analysts forecast CRVS stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CRVS is 35.7 USD with a low forecast of 27.27 USD and a high forecast of 53.55 USD.

Lowest
Price Target
27.27 USD
39% Upside
Average
Price Target
35.7 USD
82% Upside
Highest
Price Target
53.55 USD
173% Upside
Corvus Pharmaceuticals Inc Competitors:
Price Targets
CYBR
Cyberark Software Ltd
21% Upside
8841
TOC Co Ltd
23% Upside
ELAN
Elanco Animal Health Inc
5% Upside

Revenue
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-4%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-4%
Average Miss

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-60%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-60%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is CRVS's stock price target?
Price Target
35.7 USD

According to Wall Street analysts, the average 1-year price target for CRVS is 35.7 USD with a low forecast of 27.27 USD and a high forecast of 53.55 USD.

Back to Top